# SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

> **NCT00089921** · PHASE2 · COMPLETED · sponsor: **Scios, Inc.** · enrollment: 302 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** SCIO-469
- **DRUG:** SCIO-469
- **DRUG:** Placebo
- **DRUG:** SCIO-469

## Key facts

- **NCT ID:** NCT00089921
- **Lead sponsor:** Scios, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2010-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089921, "SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00089921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*